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INTRODUCTION 
Calmodulin, an endogenous calcium-binding protein, can modulate the intra- 
cellular concentration of adenosine 3',5'-cyclic monophosphate (cyclic AMP] by 
stimulating membrane-bound adenylate cyclase activity and soluble phosphodi- 
esterase (PDE) activity.' There is increasing evidence that calmodulin can 
modulate the effects of calcium at both pre- and postsynaptic sites in some areas 
of brain. Calmodulin is enriched in rat brain synaptic membranes2 and has been 
located in postsynaptic densities in mouse basal ganglia3 and canine cerebral 
~ o r t e x . ~  Previous studies have suggested that calmodulin is involved with dopa- 
mine IDA)-sensitive adenylate cyclase activity in rat striaturn. Gnegy et aL5 found 
that depletion of calmodulin t'rom striatal membranes results in a decreased 
ability of DA to stimulate adenylate cyclase activity. Furthermore, the calmodulin 
content in the striaturn was increased under conditions of dopamine supersensi- 
tivity.6 Rats treated chronically with cataleptogenic antipsychotic drugs and then 
withdrawn from the drugs hail increased calmodulin content in their striatal 
membranes. These animals exhibited behavioral supersensitivity to apomor- 
phine and their striatal adenylate cyclase had an increased affinity for dopamine 
as demonstrated by a 3- to 4-foid increase in dopamine sensitivity. The increase 
in calmodulin could positively affect DA-sensitive adenylate cyclase activity and 
thus contribute to dopaminergic: supersensitivity. 
The increased calmodulin in the striatal membranes of the supersensitive rats 
seems to be more tightly bound to its membrane binding  protein^.^ In the brain, 
calmodulin can  be hound to membrane proteins in a calcium-dependent and 
calcium-independent manner.' Calmodulin has been shown to hind to Caz+- 
dependent PDE' and Caz+-sensitive adenylate cyclase'o as well as other proteins. 
Vandermeers et (11." have demonstrated a correlation between increased 
['ZSI]calmodulin binding and activation of adenylate cyclase activity in guinea pig 
membranes. 
In this work we investigate more directly whether calmodulin can affect 
DA-sensitive activity in rat striatal membranes. We found that calmodulin could 
affect both the maximal velocity of the reaction and the sensitivity to DA. We 
studied the binding of calmodulin to striatal membranes in order to further 
investigate the relationship between calmodulin interaction with adenylate 
cyclase activity. We showed specific binding of ['251]calmodulin to striatal 
membranes that was competitively inhibited by trifluoperazine, an antipsychotic 
drug that binds to calmodulin and inhibits its action." We have also shown that 
the ability of the calmodulin content to increase could be specific for dopaminer- 
gic supersensitivity in the striatum. 
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METHODS 
Membrane Preparation 
Striatal membranes were depleted of calmodulin by a modification of the 
method of Brostrom et 01.'~ Male, Sprague-Dawley rats (150-200 g) were sacri- 
ficed by decapitation; the striata were removed and homogenized in 9 vol of 10 
mM Tris-maleate buffer, pH 7.5, containing 1 mM MgSO,, 1.2 mM EGTA, and 10 
pM guanosine triphosphate [GTP). The homogenate was centrifuged at 27,000 x g 
for 20 min, resuspended in the same buffer, and centrifuged a second time at 
27,000 x g. The pellet resulting from the final centrifugation was resuspended in 
10 mM Tris-maleate buffer, pH 7.5, containing 1.2 mM EGTA and 1 mM MgSO,. 
Adenylate Cyclase Assay 
Adenylate cyclase activity was measured in an assay (200 pl vol) containing: 
80 mM Tris-maleate buffer, pH 7.5; 5 mM MgSO,; 2 mM cyclic AMP, 4 mM 
phosphoenolpyruvate, 20 pg pyruvate kinase. 0.12 mM isobutylmethylxanthine, 
100-150 pg membrane protein, 0.15 mM EGTA [carried over from the membrane 
preparation], 1 mM [alpha-3'P]ATP (1-2 x 106 cpm/assay). with or without 
additions, such as, 10 p M  guanyl-5'-yl-irnidodiphosphate (Gpp(NH)p), 10 FM 
GTP, 125 pM CaCI,, and 500 ng (28 pmol) of highly purified calmodulin prepared 
from bovine brain according to Klee.I4 Assays were incubated for 3 min, stopped 
by heating 1 min at 95"C, and 200 p1 of a solution containing 20 mM ATP and 0.7 
mM cyclic AMP was added to the tubes. The membranes were centrifuged, and 
the [32P]-cyclic AMP in the supernatant was determined by the method of 
Krishna et 01." Recovery of the cyclic AMP was measured using [3H)-cyclic AMP 
and was 65-70%. 
Determination of Calmodulin Content 
Calmodulin was assayed by its ability to stimulate calmodulin-deficient PDE 
activityg in the PDE assay described previously.' The calmodulin content in 
nanograms was determined from a standard curve using highly purified calmod- 
ulin. 
Binding Assay 
Calmodulin was iodinated using ['251]N-succinimidyl-3-(4-hydroxyphenol) 
propionate (Bolton-Hunter reagent, Amersham) as described by Chafouleas et 
all6 and had a specific radioactivity of 428 Ci/mmol. Calmodulin binding studies 
were performed as described by Vandermeers et aI." with some modifications. 
The assay medium (in final volume of 0.2 ml) contained 80 mM Tris-maleate 
buffer, pH 7.5, 5 mM MgSO,, 0.2% bovine serum albumin, and various testing 
agents as indicated. Calmodulin ('251-labeled and non-labeled] was added to each 
assay so that the specific activity remained constant at 8 nCi/pmol of calmodulin. 
The reaction was initiated by the addition of the calcium- and calmodulin- 
depleted striatal membrane preparation (60-80 pg protein) and the reaction 
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mixture was incubated at 37°C for 2 minutes, unless otherwise indicated. To 
terminate the reaction, the sample was diluted with 2 ml of the ice-cold 
incubation buffer and filtered immediately under vacuum through a EHWP 0.5 
pm Millipore filter (Millipore Co., Bedford, Mass.) that had been prewashed with 
the buffer. The filters were rapidly washed twice with 2 ml of the same ice-cold 
buffer, dried, and counted in an Auto-gamma scintillation counter (Packard 
Model 5220). The nonspecific binding, determined by adding a 100-fold excess of 
nonlabeled calmodulin to the assay showed no significant difference from the 
assay blank (without membrane). Both the blank and the nonspecific binding 
represented less than 0.7% of the total radioactivity. Trifluoperazine, when used, 
was preincubated in the medium for 20 minutes at 37°C before the membranes 
were added. 
Membrane Calcium Determination 
Striatal membrane calcium content was measured using the method as 
described by Schmidt and Way” with some modifications. An aliquot (0.5 ml) of 
membrane fractions (4-5 mg protein) was treated with 0.5 ml of 10% trichloro- 
acetic acid (TCA). The mixture was equilibrated for 30 minutes and centrifuged 
at 5.000 x g for 15 minutes. The pellet was used to determine protein content” 
while the clear supernatant of the sample was mixed with 1 ml of 1% La3+ in 5% 
HC1. Sample blanks and standards were similarly treated. Calcium concentra- 
tions were assayed using an atomic absorption spectrophotometer (Varian Model 
AA 375). Four readings per sample were taken and averaged. The limit of 
detection by this spectrophotometric method was 5 nmol calcium/0.5 ml sample. 
The free calcium concentration reported in the binding studies was calcu- 
lated according to Nanninga and Kempen” where the concentrations of EGTA 
and M&+ and the buffer pH were taken into consideration. All data were 
calculated in terms of mean + S.E.M. Statistical analysis was performed using 
the t test either for unpaired or for paired comparison whenever appropriate. A 
P < 0.05 was considered significant. 
RES~JLTS 
Effect of Calrnodulin and Calcium on Basal Adenylate Cyclase Activity 
Depletion of most of the calrnodulin content from the striatal membranes was 
necessary to observe the stimulatory effects of this protein on adenylate cyclase 
TABLE 1 
CALMODULIN CONTENT, CALCIIJM CONTENT. A N D  ADENYLATE CYCLASE ACTIVITY 
IN RAT STRIATAL MEMRRANES BEFORE AND AFTER EGTA TREATMENT 
Membrane Membrane Adenylate 
Calmodulin Calcium Cyclase 
Content Content Activity 
Buffer 4.9 t 0.6(3) 12.3 t 0.8(5) 175 2 7 (3)  
Buffer + EGTA 2.9 2 0.3 (3) not detectable (10) 105 f 17 (3)  
Conditions (pg/mg protein) (nmoI/mg protein) (pmol/min/mg protein) 
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TABLE 2 
EFFECT OF CALCIUM AND CALMODULIN O  BASAL ADENYLATE CYCLASE ACTIVITY 
IN RAT STRIATAL MEMBRANES 
Calcium added 
to Assav 
Adenylate Cyclase Activity 
Ipmol/min/rnn protein ? S.E.M.1 
l@M). - Calmodulin + Calrnodulin 
0 96 -t 6 (4) 76 ? 11 (4) 
50 97 * 12  78 k 10 
125 86 f 10 145 f 18 
200 80 ? 14 105 ? 16 
100 94 t 16 135 ? a 
activity. The EGTA treatment depleted most, but not all, of the calmodulin from 
the membrane fraction. As shown in TABLE 1, the calmodulin content in the 
membranes was depleted by 41% after EGTA treatment. Originally, nearly 50% 
of the calmodulin content in the brain cell is located in the membranes. EGTA 
washing similarly decreased the specific activity of the basal adenylate cyclase 
activity in the membrane fraction by 41% (TABLE 1). The calcium content in 
EGTA-washed membranes was below the level of detection. 
Neither calcium nor calmodulin individually were able to stimulate basal 
adenylate cyclase activity in the striatum. Calcium itself did not really affect 
basal activity until high concentrations were added (>ZOO pM]. Calmodulin and 
calcium added together had a biphasic action on adenylate cyclase activity 
(TABLE 2). In the presence of 500 ng of calmodulin (1.4 x M), concentrations 
of calcium added between 50 pM and 150 pM elicited stimulation of adenylate 
cyclase activity with a maximum effect at 125 pM calcium. Adenylate cyclase 
activity was inhibited at concentrations of calcium of less than 50 pM or greater 
than 200 pM in the presence of calmodulin. The effective concentrations of 
calcium providing stimulation was actually very low because the assay contained 
150 pM EGTA. Using a KD for Ca-EGTA calculated according to Nanninga and 
Kernpen,” addition of 125 pM calcium will result in an effective concentration of 
0.14 p M  calcium. 
As shown in FIGURE 1, guanyl nucleotides were able to produce a greater 
maximal stimulation of adenylate cyclase than did calmodulin. 10 pM Gpp(NH)p 
stimulated the adenylate cyclase activity by 200%. Calcium significantly inhib- 
ited the Gpp(NH)p-stimulated adenylate cyclase activity by 60%. Addition of 
calmodulin reversed the calcium inhibition with the result that the stimulation by 
Gpp(NH)p, calcium, and calmodulin was the same as that of Gpp(NH)p alone. 
The interaction of calcium and calmodulin with GTP stimulation of basal activity 
qualitatively differed from that observed with Gpp(NH)p. GTP-stimulated 
adenylate cyclase activity was slightly stimulated by both calcium and calmodu- 
lin. Calcium will inhibit GTP-stimulated adenylate cyclase activity but much 
greater concentrations of calcium are required (200 pM added calcium, which is 
> 2  pM effective calcium). Stimulation of adenylate cyclase activity by calmodu- 
lin was specific because troponin C, calcium-binding protein from muscle, did 
not stimulate basal adenylate cyclase activity even at 10-fold higher concentra- 
tions. Furthermore, troponin C did not reverse the effects of calcium on 
Gpp(NH)p stimulation as did calmodulin. 
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FIGURE I. Stimulation of adenylate cyclase activity in rat striatum by calmodulin and 
guanyl nucleotides. Adenylate cyclase assays were performed as described in METHODS 
with the following additions: 10 pM Gpp(NH)p [GPP(NJP) or GTP; 500 ng of calmodulin 
(CaM] or 125 pM CaCI2. The number of experiments is given in parentheses. *P i 0.01 as 
compared to the value far Gpp(NH]p alone. 
Effect of Calmodulin on DA-Sensitive Adenylate Cyclase Activity 
Adenylate cyclase activity in striatal membranes that had been washed 
repeatedly with EGTA could not be stimulated by DA. Addition of calcium, 
calmodulin. or both agents together was insufficient to restore DA sensitivity. 
Inclusion of 10 p M  Gpp(NH)p or GTP in the assay was necessary to achieve 2 
dose-dependent response to DA in the formation of cyclic AMP. Adenylate 
cyclase activity was stimulated 1.4-1.5 fold by DA in the presence of 10 p M  
Gpp(NH)p. This actually represented a large stimulation over the original basal 
activity (TABLE 1). The increase in adenylate cyclase activity in the presence of 10 
pM Gpp(NH)p reached a maximum at 5 p M  DA. The K,,, for DA in the presence 
of Gpp(NH)p was 1.1 pM and the V,,, was 100 pmol/min/mg protein (TABLE 3). 
Addition of 125 pM calcium brought about a 50% decrease in V,,, with no 
TABLE 3 
KINEI'IC CONSTANTS FOR STIMLJLATION OF STRIATAL DOPAMINE-SENSITIVE AD NYLATE 
CYCLASE B Y  GPP(NH)P, CALCILlhl. A N D  CALMODULIN 
Additions to K,,, vmax 
Assav (/AM f S.E.M.1 lumol/min/me. urotein i S.E.M.1 
GPP"H1P 151 1.1 _t 0.2 100 f 15 
Gpp(NH)p + Ca" (5) 0.83 ? 0.1 45 f 5** 
+ calmodulin 0.56 t 0.1* 77 ? 12 
GppINHJp + Ca" (51 
*P < 0.005 as compared to value with Gpp(NH]p alone or Gpp(NH)p + Ca". 
**P c. 0.02 as compared to value with Gpp(NH]p alone or Gpp(NHJp + Ca'+ + 
calmodulin. 
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TABLE 4 
KINETIC CONSTANTS FOR STIMULATION OF STRIATAL DOPAMINE-SENSITIVE ADENYLATE 
CYCLASE ACTIVITY IN THE PRESENCE OF GTP, CALCIUM AND CALMODULIN 
Additions to Kact v,,, 
Assay (fiM S.E.M.) (pmol/min/mg protein * S.E.M.) 
3.8 t 0.7 
5.2 & 0.1 
122 k 9 
68 k 8** 
GTP (81 
GTP + Caz+ (5) 
GTP + CaZf (8) 
+ Calmodulin 1.8 k 0.4* 112 t 10 
*P < 0.04 as compared to value with GTP alone or GTP + Caz+. 
**P < 0.001 as compared to value with GTP alone or GTP + Ca2+ + calmodulin. 
change in sensitivity for DA. When 500 ng of calmodulin was added with the 
calcium, the maximal velocity was restored to 80% of the value found with 
Gpp(NH)p alone and the dose response curve for DA was shifted in a parallel 
manner to the left. The K,,, for DA was decreased &fold to 0.56 pM (TABLE 3). The 
average kinetic parameters of 5 separate experiments for DA stimulation of 
adenylate cyclase in the presence of Gpp(NH)p are shown in TABLE 3. 
The same pattern was seen for the effects of calcium and calmodulin on 
DA-stimulated activity in the presence of 10 pM GTP. Adenylate cyclase activity 
was stimulated 1.7-1.8 fold by DA in the presence of 10 pM GTP. The K,,, for DA 
stimulation of adenylate cyclase was 3.8 FM (TABLE 4), nearly 3 times greater than 
that found in the presence of Gpp(NH)p. The V,,, of the reaction (122 pmol/ 
min/mg protein] was slightly greater, however, than that obtained with 
Gpp(NH)p. Addition of 125 pM calcium to the assay again decreased DA 
stimulation, in spite of the fact that calcium did not decrease GTP stimulation of 
GFUNP 
C 0' 
FIGURE 2. Effect of troponin C on maximal velocity of dopamine-sensitive adenylate 
cyclase activity in rat striatum. The V,, of the dopamine-sensitive adenylate cyclase 
reaction was calculated from Lineweaver Burk plots from 3 different experiments. Concen- 
trations of additions are: 1OpM Gpp(NH)p (GPP(N)P), 500 ng calmodulin (CaM), 500 ng or 5 
pg troponin C (TnC), or 125 pM CaCI,. *P < 0.05 as compared to the value for Gpp(NH)p 
alone. 
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basal activity. In this case calcium reduced the V,,, &fold with no significant 
change in the K,,, for DA. Addition of calmodulin with the calcium elicited an 
increase in V,,, to the level found with GTP alone and resulted in a &fold 
sensitivity for DA [Kac, for DA = 1.8 pM). Kinetic constants for DA-stimulation of 
adenylate cyclase in the presence of GTP for 8 different experiments are shown 
in TABLE 4. 
The effect of calmodulin on DA-sensitive adenylate cyclase activity was 
specific for calmodulin in the capacity of a calcium-binding protein. Troponin C 
could not completely substitute for the effects of calmodulin on the maximal 
velocity of DA-stimulated activity even at nearly 10-fold higher concentration 
than calmodulin (FIGURE 3). The molecular weight of troponin C is 17,800 
daltons.20 Troponin C did not increase the affinity for DA. 
Binding of /'"I/ Calrnodulin to Striatal Membranes 
Although the experiments using troponin C indicated a specific interaction of 
calmodulin with adenylate cyclase, we wished to show that calmodulin was able 
to bind specifically to striatal membranes under the conditions of the adenylate 
cyclase assay. Therefore, we developed an assay to measure the binding of 
[1251]calmodulin to striatal membranes depleted of calcium and calmodulin. The 
dependence of calmodulin binding upon time and temperature was determined 
in the presence of 1.25 x M added calcium (0.14 p M )  in membranes 
previously depleted of calcium and calmodulin. Binding of [1251] calmodulin was 
0 2 4 6 8 10 
TI  ME (MINUTE 1 
FIGURE 3. Effects of time and temperature on ['ZSI]calmodulin binding in rat striatal 
memhranes. The membranes were depleted of calcium and calmodulin as described in the 
METHODS. The assays contained 1.25 x lo-' M CaCI,. "Value significantly lower than the 
peak binding response at 2 min. N = 4. 
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FIGURE 4. Effect of calcium on ['Z51]calmodulin binding in rat striatal membranes. Free 
calcium concentrations in the assay were calculated according to Nanninga and Kernpen.'' 
The assays were incubated at 37°C for 2 minutes. N = 3. *Significantly different from the 
value when no calcium was added. 
found to be rapid and maximal binding was reached after 2 minutes of incuba- 
tion. However, the binding decreased when incubation was continued at 37°C 
(FIGURE 3). The extent of calmodulin binding was markedly decreased when 
incubation was performed at 0°C [FIGURE 3) but the time-dependent decrease 
was not seen. A protease could be destroying the calmodulin at the higher 
temperature. 
Calmodulin binding to calcium- and calmodulin-depleted membranes was 
dependent on the concentration of calcium added into the assay. Calmodulin 
binding was substantially enhanced by increasing concentrations of calcium 
(FIGURE 4). 1.25 x M calcium (1.4 x lo-' M calculated free Caz+] exhibited a 
maximal binding of calmodulin to the membranes, while calcium less than 1 O P  
M (2 x lo-' M free Caz+) did not affect the binding significantly, as compared to 
the binding with no calcium added (FIGURE 4). 
Calmodulin binding to the striatal membranes was saturable; saturation being 
reached at 500 ng of calmodulin (1.4 x M 
calcium. Trifluoperazine M) produced a significant shift of the control 
calmodulin-binding to the right (FIGURE 5). In four experiments, trifluoperazine 
at M the 
drug did not produce further inhibition of calmodulin binding than at M 
(data not shown). 
The above results (FIGURE 5) were plotted according to the Scatchard analysis. 
Saturation of binding occurred with a maximal number of binding sites of 11.8 
1.2 pmol/mg protein (determined by extrapolation from 11 experiments] [TABLE 
5) .  The Scatchard plot, as well as the displacement curve, suggests that there are 
M] in the presence of 1.25 x 
M did not antagonize calmodulin binding significantly and at 
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FIGURE 5. Effect of trifluoperazine (lo-' M) on the dose-response curve of ['251]calmodu- 
lin binding in rat striatal membranes. Trifluoperazine was preincubated for 20 minutes at 
37°C in the presence of 1.25 x lo-' M CaC1, before the membranes were added. The 
binding reaction was carried out at 37°C for 2 minutes. *Significantly different from control 
value. 
two populations of calmodulin binding sites: a higher-affinity binding site with a 
dissociation constant (K,) of 1.3 >: M and a lower-affinity binding site with a 
K, of 2.9 x M (TABLE 5). When the calmodulin binding curve was evaluated 
by Hill analysisz1 to determine whether there were cooperative interactions 
among the binding sites, a linear Hill plot with a coefficient of 0.90 f 0.14 (95% 
confidence limit) was obtained. This may suggest that there is no appreciable 
cooperativity among calmodulin binding sites. 
M) on calmodulin binding was also 
analyzed by the Scatchard method. The analysis revealed that the higher-affinity 
The effect of trifluoperazine 
TABLE 5 
EFFECT OF 10 -' M TRIFLUOPERAZINE ON ['ZSI]CALMODULIN BINDING 
I N  RAT STRIATAL MEMBRANES* 
Control (lilt + lo-' M Trifluoperazine (511- 
Higher affinity binding 
Number of sites 
APP. K D  1.3 lo- '  M 1.4 x 1W'M 
Number of sites 
APP. KD 2.9 x M 1.3 x MS 
*All values were determined from Scatchard plot. 
tNumber of experiments. 
+Significantly different from control values (P  < 0.05). 
8.5 i 0.8 pmol/mg protein 3.3 t 0.4 pmol/mg protein$ 
Lower affinity binding 
11.8 + 1.2: pmol/mg protein 13.3 -t 1.5 pmol/mg protein 
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binding component for calmodulin was significantly inhibited by trifluoperazine 
(iw4 M), while the KO for lower-affinity binding component was increased 
(TABLE 5). 
Alterations in Calmodulin Content During Supersensitivity 
to Catecholamines in Brain 
We have shown previously that calmodulin content was increased in rat 
striatal membranes after chronic treatment with cataleptogenic antipsychotic 
drugs.’ Furthermore, Lucchelli et aJ.** have shown increases in striatal content of 
calmodulin in rat striatum after hemisection, indicating that increases in calmod- 
ulin will occur after supersensitivity to dopamine is produced by a variety of 
means. We wished to investigate whether other dopaminergic areas, such as the 
hypothalamus and the limbic system, had increased calmodulin content as well. 
The calmodulin content was measured in the membranes (27,000 x g fraction] of 
TABLE 6 
CALMODULIN CONCENTRATION IN MEMBRANES OF SEVERAL BRAIN AREAS FROM RATS 
TREATED CHRONICALLY WITH SALINE AND HALOPERIDOL* 
Calmodulin 
Saline Haloperidol 
Area N (pg/mg membrane protein * S.E.M.) 
Striatum 8 4.0 c 0.2 5.1 2 0.1t 
Nucleus Accumbens 5 3.3 * 0.1 3.2 t 0.1 
Hypothalamus 13 3.5 c 0.2 2.9 t O.Z$ 
*Male Sprague Dawley rats were injected daily for 20 days with 2.5 pmol/kg [s.c.) 
haloperidol or 0.1 ml saline. One week after stopping chronic injections the rats were 
sacrificed and calmodulin content was measured as described in METHODS. 
t P  < 0.05 as compared to value for saline-treated animals. 
*P < 0.001 as compared to value for saline-treated animals. 
the hypothalamus and nucleus accumbens after chronic haloperiodol treatment 
in rats. The rats were treated as described in TABLE 6. As TABLE 6 illustrates, the 
only area showing an increase in membrane calmodulin after chronic haloperi- 
do1 treatment was the striatum. A decrease in calmodulin was found in the 
membrane fraction of the hypothalamus but the change was quite small. At the 
present time the significance of this is obscure. 
The ability of calmodulin content to be altered under conditions of noradren- 
ergic supersensitivity was examined. Treatment of rats with reserpinez3 or 
6-hydroxydopaminez4 (6-OHDA) can result in supersensitivity of noradrenergic 
receptors in the cerebral cortex. In order to examine whether calmodulin could 
be involved in modulating NE responses in the brain, supersensitivity to NE was 
developed by these methods. One group of rats was treated with reserpine (2.5 
mg/kg i.p.1 for four days and sacrificed 4 hours later. The calmodulin content in 
the membranes (27,000 x g fraction] of the cerebral cortex was measured. In 
another experiment rats were injected intraventricularly on two successive days 
with 6-OHDA (200 pg) as described by Kalisker et Two weeks later the 
animals were sacrificed and calmodulin was measured in the membrane 
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fractions (27,000 x g] from the cerebral cortex and striatum. The results are 
shown in TABLE 7. The calmodulin content did not change in the cerebral cortex 
of rats subjected to either drug treatment. The calmodulin content was, however, 
significantly increased in the striatal membranes of 6-OHDA rats. This is not too 
surprising since intraventricularly administered 6-OHDA can cause extensive 
depopulation in the zona compacta of the substantia nigra. Although NE- 
sensitive adenylate cyclase activity was not measured, the appearance of nor- 
adrenergic supersensitivity in the cortex after these treatments is well docu- 
mented. 
DISCUSSION 
The participation of calcium in catecholamine-stimulated adenylate cyclase 
activity in the brain is nct well understood. Calcium has generally been consid- 
TABLE 7 
CALMODULIN CONTENT IN MEMBRANES OF RAT CEREBRAL CORTEX AND STRIATUM 
AITER 6-OHIIA OR RESERPINE TREATMENT 
Calmodulin Concentration 
Treatment 
Striatum Cerebral Cortex 
(pg/mg protein -t S.E.M.) 
Saline (5) 5.0 % 0.3 5.2 * 0.2 
6-OHDA (5)* 6.2 e O:l$ 5.5 2 0.4 
Saline (8) 5.0 f 0.3 
Reserpine (8) 5.1 c 0.3 
*s-OHDA-treated rats were injected intraventricularly using stereotoxic coordinates 
with 200 fig of 6-OHDA on each of 2 successive days. Animals were sacrificed 2 weeks after 
last injection. 
tReserpine-treated rats were treated daily with reserpine (2.5 mg/kg i.p.) for 4 days and 
sacrificed 4 hours after last injection. Number of animals is given in parentheses. 
$P 0.001 when compared to value for saline-treated animals. 
ered to be inhibitory to DA-sensitive adenylate cyclase activity in the striatum 
because stimulation in homogenates can only he detected in the presence of 
EGTA, a calcium chelating agent. This effect occurred because EGTA decreased 
basal adenylate cyclase activity and permitted expression of DA s e n s i t i ~ i t y . ~ ~  In 
other systems, however, calcium has been shown to enhance catecholamine 
stimulation of cyclic AMP production. For example. extracellular calcium is 
required for the increased production of cyclic AMP by a-adrenergic agonists in 
cerebral cortical slices.26 A stronger role for a stimulatory effect of intracellular 
calcium in NE-stimulation of cyclic AMP production was shown by Brostrom et 
aLZ7 using C6 glioma cells. The ability of C6 glioma cells to accumulate cyclic 
AMP in response to NE was reduced 60-70% following nearly total calcium 
depletion of the cells in culture by EGTA. 
Since calmodulin is so integrally involved with the effects of calcium on 
cyclic nucleotide metabolism in the brain, one cannot properly determine the 
effects of calcium without consideration of calmodulin. Calmodulin is present in 
brain membranes and is enriched in synaptic membranes.’ Therefore, we 
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studied the effects of calcium and calmodulin on basal and DA-stimulated 
adenylate cyclase activity in calcium and calmodulin depleted rat striatal 
membranes. 
We found that calmodulin stimulated basal adenylate cyclase activity in a 
biphasic manner that was dependent upon the concentration of calcium. Stimu- 
lation of adenylate cyclase by calmodulin was maximal at an effective calcium 
concentration of 0.14 pM which is within resting levels of calcium in nerve 
membranes.” Calcium and calmodulin inhibited adenylate cyclase activity at 
higher concentrations of calcium. The effects of calmodulin on basal adenylate 
cyclase activity would conceivably depend on calcium flux in the membrane. At 
resting levels of calcium, adenylate cyclase activity would be increased by 
calmodulin but as calcium levels rise the system would become inhibited. 
DA sensitivity was abolished in calcium and calmodulin-depleted 
membranes and could not be restored by addition of either agent. A dose 
dependent stimulation of adenylate cyclase by DA was found only when guanyl 
nucleotides were included in the assay at concentrations of at least 10 p M .  
Similar results were found by Sulakhe et 01.” Addition of 125 pM calcium 
inhibited DA-stimulated adenylate cyclase activity in the presence of either 
guanyl nucleotide. When calmodulin was present, however, the maximal veloc- 
ity of the reaction was somewhat restored and the sensitivity to DA was 
increased. Thus calmodulin affected both the K, for DA and V,,, of the 
DA-sensitive adenylate cyclase activity. This suggests that at physiological, 
resting concentrations of calcium, DA will not greatly stimulate adenylate cyclase 
activity unless calmodulin is present. 
The exact molecular mechanism in which calmodulin affects DA-sensitive 
adenylate cyclase activity is not yet known. Calmodulin could be simply acting as 
a calcium scavenger, preventing it from inhibiting DA-sensitive adenylate 
cyclase. There are several findings that do not support this explanation. First, 
calmodulin actually stimulated basal adenylate cyclase activity in the presence of 
calcium. Calcium alone had little effect on basal adenylate cyclase activity until 
very high concentrations. Second, troponin C, a calcium-binding protein with 
some sequence homology to calmodulin and a similar molecular weight, did not 
mimic the action of calmodulin on basal or DA-stimulated adenylate cyclase 
activity, even at concentrations ten times that of calmodulin. Troponin C actually 
binds calcium with an affinity similar to that of calmodulin. Third, we have 
shown that under conditions used in this assay, [1251]calmodulin will bind to the 
striatal membranes in a calcium-dependent manner. The binding was specific 
for calmodulin and was inhibited by trifluoperazine, an antipsychotic drug 
known to bind calmodulin. We found that there were at least two classes of 
binding sites for calmodulin in the membranes. The fact that trifluoperazine 
mainly affected the higher affinity binding site suggests that this site in the 
striatum could play an important role in mediating the action of trifluoperazine. 
It is highly likely that there is an interaction between calcium. calmodulin, 
and the guanyl nucleotide binding protein in brain membranes. Wescott et al.” 
found that a guanyl nucleotide-sensitive fraction was required for calmodulin 
stimulation in a purified calmodulin-dependent adenylate cyclase preparation 
from cerebral cortex. We found, as have others,” that both GTP and Gpp(NH)p 
stimulated basal adenylate cyclase activity in our membrane preparation and 
were required for DA stimulation. The effects of guanyl nucleotides on basal and 
DA-stimulated adenylate cyclase activity are variable and may depend on the 
type of membrane or homogenate preparati~n.~’ In our preparation, Gpp(NH)p 
stimulation of adenylate cyclase activity was much more sensitive to calcium 
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inhibition than was GTP stimulation. Calcium, did, however, decrease DA 
stimulation of adenylate cyclase activity in the presence of both Gpp(NH)p and 
GTP. The molecular association induced by Gpp(NH)p in striatal membranes 
may be similar to that achieved in the presence of GTP and hormone. In this 
respect the role of guanyl nucleotides in dopamine receptor activation could 
parallel their mechanism of activation of the P-adrenergic receptor in erythro- 
cy te~ .~ ’  Our data suggest that it is this association or “activation state” achieved by 
Gpp(NH)p or DA that can be inhibited by calcium and with which calmodulin 
can interact. 
Our present findings correlate with our previous work concerning the 
relationship between calmodulin and dopaminergic supersensitivity in rat stria- 
t ~ m . ~ . ~ ’  Animals chronically treated with antipsychotic drugs had increased 
calmodulin content in their striatal membranes. The adenylate cyclase in the 
striatal membranes of the drug-treated animals showed an increased sensitivity 
to DA as shown by a 3-fold decrease in the apparent K, for DA. This further 
supports a role for calmodulin in dopaminergic activity and even supersensitivity 
to DA in the rat striatum. 
Our results indicate that calmodulin is mainly important for dopaminergic 
supersensitivity in the striaturn, although we did not do experiments validating 
that there was dopaminergic supersensitivity occurring in the other areas. The 
strong change of calmodulin seen in the striatum may be due to the feedback 
regulation mechanism of the nigrostriatal system. The difference in regulation of 
the striatal receptors could account for these results. Similarly, the amount of 
calmodulin did not change a membrane fraction from the cerebral cortex of rats 
made supersensitive to NE. There is evidence that calmodulin is important for 
adrenergic stimulation of cyclic AMP in the brain27.33 so its possible participation 
in adrenergic supersensitivity may occur in a more subtle manner. We can 
conclude that in rat striatum, during normal synaptic activity or under conditions 
of greatly altered synaptic inpiit, calmodulin could be vital in attempting to 
maintain normal dopaminergic: function through stimulatory and inhibitory 
effects. 
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DISCIJSSION OF THE PAPER 
DR. D. FLOCKHART (Vanderbilt University, Nashville, TN): Do you consider it 
possible that your two calmodulin affinities are actually due to two different 
populations of iodonated calmodulin? 
DR. N. GNEGY: We put iodonated calmodulin over gels. It seems to be a pure 
species. 
DR. FLOCKHART: Yes, but, you can have a mono-, di- or tri-iodonated calmodu- 
lin which would have altered it. 
DR. GNEGY: Well, our stoichiometry doesn't seem to support that but it is 
always possible. 
DR. WOLFE (National Institutes of Health, Bethesdo, MD): If the calmodulin 
interacts with the G subunit you should be able to affect A T P  ribosylation with 
cholera toxin and NAD. Have you tried such experiments? 
DR. GNEGY: No. But I think due to the experiments of Moss and Vaughn I 
would say it seems a very likely possibility because they showed that calmodulin 
can affect cholera toxin action in the brain. Another thing I had to take into 
account going along with the work shown by the Brostroms is that there could be 
two forms of cyclase in the membrane, one calcium sensitive, one not, and one 
may be inhibited by calcium and the other stimulated. So, what I may be looking 
at is an interplay between the two. 
